Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3326-3332

  Robertson, M Denise ^a   Wright, John W ^a   Loizon, Emmanuelle ^b   Debard, Cyrille ^b   Vidal, Hubert ^b   Shojaee Moradie, Fariba ^a   Russell Jones, David ^a   Umpleby, A Margot ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b CarMeN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH AMYLOSE MAIZE RESISTANT STARCH TYPE 2; HORMONE SENSITIVE LIPASE; LIPOPROTEIN LIPASE; PERILIPIN; PLACEBO; STARCH; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BIOPSY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY FIBER; FATTY ACID METABOLISM; FEMALE; FOOD COMPOSITION; FOOD INTAKE; FOREARM; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; UNITED KINGDOM;

ADIPOSE TISSUE; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CYTOKINES; DIET; DIETARY FIBER; FEMALE; GENE EXPRESSION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MEMBRANE POTENTIALS; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SINGLE-BLIND METHOD; ZEA MAYS;

ZEA MAYS;

EID: 84866158296     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1513     Document Type: Article

References (34)

1. American Diabetes Association 2008 Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615
2. Bloomgarden ZT 2009 The 6th Annual World Congress on the Insulin Resistance Syndrome. Diabetes Care 32:e127-e133
3. Risérus U, Willett WC, Hu FB 2009 Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 48:44-51
4. Smith CE, Tucker KL 2011 Health benefits of cereal fibre: a review of clinical trials. Nutr Res Rev 1-14
5. Jenkins DJ, Kendall CW, Axelsen M, Augustin LS, Vuksan V 2000 Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coranary heart disease. Curr Opin Lipidol 11:49-56 (Pubitemid 30148198)
6. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN 2005 Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82:559-567
7. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN 2003 Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46:659-665 (Pubitemid 36814018)
8. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD 2010 Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 27:391-397
9. Weickert MO, Möhlig M, Schöfl C, Arafat AM, Otto B, Viehoff H, Koebnick C, Kohl A, Spranger J, Pfeiffer AF 2006 Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 29:775-780 (Pubitemid 44115293)
10. Robertson MD 2007 Metabolic cross talk between the colon and the periphery: implications for insulin sensitivity. Proc Nutr Soc 66:351-361
11. Robertson MD 2012 Dietary resistant starch and glucose metabolism. Curr Opin Clin Nutr Metab Care 15:362-367
12. Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E 2008 Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism 57:355-361 (Pubitemid 351178724)
13. Englyst HN, Kingman SM, Cummings JH 1992 Classification and measurement of nutritionally important starch fractions. European Journal of Clinical Nutrition 46(Suppl 2):S33-S50
14. Coppack SW, Frayn KN, Humphreys SM, Whyte PL, Hockaday TD 1990 Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism 39:384-390 (Pubitemid 20146590)
15. Otway DT, Mäntele S, Bretschneider S, Wright J, Trayhurn P, Skene DJ, Robertson MD, Johnston JD 2011 Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic. Diabetes 60:1577-1581
16. Shojaee-Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM 1996 Quantitative measurement of 3-O-methyl-Dglucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrom 31:961-966
17. Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, Vouillarmet J, Peretti N, Rabasa-Lhoret R, Laville M, Vidal H, Rieusset J 2011 FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes 60:258-268
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
19. Steele R 1959 Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
20. Finegood DT, Bergman RN, Vranic M 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924 (Pubitemid 17136807)
21. Finegood DT, Bergman RN 1983 Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244:E472-E479 (Pubitemid 13088287)
22. Weickert MO, Roden M, Isken F, Hoffmann D, Nowotny P, Osterhoff M, Blaut M, Alpert C, Gögebakan O, Bumke-Vogt C, Mueller F, Machann J, Barber TM, Petzke KJ, Hierholzer J, Hornemann S, Kruse M, Illner AK, Kohl A, Loeffelholz CV, Arafat AM, Möhlig M, Pfeiffer AF 2011 Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94:459-471
23. Watt MJ, Carey AL, Wolsk-Petersen E, Kraemer FB, Pedersen BK, Febbraio MA 2005 Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion. Diabetologia 48:105-112 (Pubitemid 40174662)
24. Berndt J, Kralisch S, Klöting N, Ruschke K, Kern M, Fasshauer M, Schön MR, Stumvoll M, Blüher M 2008 Adipose triglyceride lipase gene expression in human visceral obesity. Exp Clin Endocrinol Diabetes 116:203-210 (Pubitemid 351600581)
25. Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, Fielding BA, Karpe F 2006 The in vivo effects of the Pro12 Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia 49:158-168 (Pubitemid 43151627)
26. Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Rydén M, Arner E, Sicard A, Jenkins CM, Viguerie N, van Harmelen V, Gross RW, Holm C, Arner P 2005 Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54:3190-3197 (Pubitemid 43334374)
27. Kim HJ, Jung TW, Kang ES, Kim DJ, Ahn CW, Lee KW, Lee HC, Cha BS 2007 Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. Metabolism 56:676-685 (Pubitemid 46574731)
28. Tan GD, Debard C, Funahashi T, Humphreys SM, Matsuzawa Y, Frayn KN, Karpe F, Vidal H 2005 Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 48:1585-1589 (Pubitemid 41175512)
29. Tan GD, Olivecrona G, Vidal H, Frayn KN, Karpe F 2006 Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. Diabetologia 49:2412-2418 (Pubitemid 44359103)
30. Maki KC, Pelkman CL, Finocchiaro ET, Kelley KM, Lawless AL, Schild AL, Rains TM 2012 Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. J Nutr 142:717-723
31. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R 2011 Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506-2514
32. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI 2005 Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603-608 (Pubitemid 40322060)
33. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM 2009 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091-1103
34. Bird AR, Conlon MA, Christophersen CT, Topping DL 2010 Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes 1:423-431